nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethosuximide—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0478	0.0601	CbGbCtD
Ethosuximide—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0478	0.0601	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0413	0.0519	CbGbCtD
Ethosuximide—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0413	0.0519	CbGbCtD
Ethosuximide—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.0401	0.0504	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.0401	0.0504	CbGbCtD
Ethosuximide—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0397	0.0498	CbGbCtD
Ethosuximide—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.0363	0.0455	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.0363	0.0455	CbGbCtD
Ethosuximide—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.0363	0.0455	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.0363	0.0455	CbGbCtD
Ethosuximide—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0359	0.0451	CbGbCtD
Ethosuximide—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0359	0.0451	CbGbCtD
Ethosuximide—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.035	0.044	CbGbCtD
Ethosuximide—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.031	0.0389	CbGbCtD
Ethosuximide—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0301	0.0378	CbGbCtD
Ethosuximide—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0272	0.0342	CbGbCtD
Ethosuximide—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0272	0.0342	CbGbCtD
Ethosuximide—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0165	0.0207	CbGbCtD
Ethosuximide—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0155	0.0194	CbGbCtD
Ethosuximide—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0155	0.0194	CbGbCtD
Ethosuximide—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.014	0.0176	CbGbCtD
Ethosuximide—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.014	0.0176	CbGbCtD
Ethosuximide—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0121	0.0152	CbGbCtD
Ethosuximide—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0117	0.0147	CbGbCtD
Ethosuximide—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0106	0.0133	CbGbCtD
Ethosuximide—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0106	0.0133	CbGbCtD
Ethosuximide—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0102	0.0128	CbGbCtD
Ethosuximide—Urethral disorder—Ritonavir—acquired immunodeficiency syndrome	0.000387	0.00192	CcSEcCtD
Ethosuximide—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.000383	0.0019	CcSEcCtD
Ethosuximide—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.000378	0.00187	CcSEcCtD
Ethosuximide—Agitation—Indinavir—acquired immunodeficiency syndrome	0.000378	0.00187	CcSEcCtD
Ethosuximide—Agranulocytosis—Lamivudine—acquired immunodeficiency syndrome	0.000377	0.00187	CcSEcCtD
Ethosuximide—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000377	0.00187	CcSEcCtD
Ethosuximide—Urinary tract disorder—Saquinavir—acquired immunodeficiency syndrome	0.000376	0.00186	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.000374	0.00185	CcSEcCtD
Ethosuximide—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.000374	0.00185	CcSEcCtD
Ethosuximide—Connective tissue disorder—Saquinavir—acquired immunodeficiency syndrome	0.000374	0.00185	CcSEcCtD
Ethosuximide—Erythema multiforme—Ritonavir—acquired immunodeficiency syndrome	0.000374	0.00185	CcSEcCtD
Ethosuximide—Urethral disorder—Saquinavir—acquired immunodeficiency syndrome	0.000373	0.00185	CcSEcCtD
Ethosuximide—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.000372	0.00184	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000372	0.00184	CcSEcCtD
Ethosuximide—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.000371	0.00184	CcSEcCtD
Ethosuximide—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.000371	0.00184	CcSEcCtD
Ethosuximide—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.000369	0.00183	CcSEcCtD
Ethosuximide—Eye disorder—Ritonavir—acquired immunodeficiency syndrome	0.000369	0.00183	CcSEcCtD
Ethosuximide—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.000362	0.0018	CcSEcCtD
Ethosuximide—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000361	0.00179	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00036	0.00178	CcSEcCtD
Ethosuximide—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	0.00036	0.00178	CcSEcCtD
Ethosuximide—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000359	0.00178	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000359	0.00178	CcSEcCtD
Ethosuximide—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.000358	0.00178	CcSEcCtD
Ethosuximide—Muscle spasms—Delavirdine—acquired immunodeficiency syndrome	0.000358	0.00177	CcSEcCtD
Ethosuximide—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.000357	0.00177	CcSEcCtD
Ethosuximide—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000357	0.00177	CcSEcCtD
Ethosuximide—Connective tissue disorder—Lamivudine—acquired immunodeficiency syndrome	0.000357	0.00177	CcSEcCtD
Ethosuximide—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000356	0.00176	CcSEcCtD
Ethosuximide—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000356	0.00176	CcSEcCtD
Ethosuximide—Eye disorder—Saquinavir—acquired immunodeficiency syndrome	0.000356	0.00176	CcSEcCtD
Ethosuximide—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000354	0.00175	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000353	0.00175	CcSEcCtD
Ethosuximide—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000353	0.00175	CcSEcCtD
Ethosuximide—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000353	0.00175	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000352	0.00174	CcSEcCtD
Ethosuximide—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000351	0.00174	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000348	0.00172	CcSEcCtD
Ethosuximide—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.000346	0.00172	CcSEcCtD
Ethosuximide—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000344	0.00171	CcSEcCtD
Ethosuximide—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.000344	0.0017	CcSEcCtD
Ethosuximide—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000344	0.0017	CcSEcCtD
Ethosuximide—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000343	0.0017	CcSEcCtD
Ethosuximide—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.000343	0.0017	CcSEcCtD
Ethosuximide—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000343	0.0017	CcSEcCtD
Ethosuximide—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000342	0.00169	CcSEcCtD
Ethosuximide—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000342	0.00169	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000341	0.00169	CcSEcCtD
Ethosuximide—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.00034	0.00169	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.00034	0.00168	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000335	0.00166	CcSEcCtD
Ethosuximide—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000334	0.00165	CcSEcCtD
Ethosuximide—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.000333	0.00165	CcSEcCtD
Ethosuximide—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000333	0.00165	CcSEcCtD
Ethosuximide—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.000331	0.00164	CcSEcCtD
Ethosuximide—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000331	0.00164	CcSEcCtD
Ethosuximide—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000331	0.00164	CcSEcCtD
Ethosuximide—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.000331	0.00164	CcSEcCtD
Ethosuximide—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000331	0.00164	CcSEcCtD
Ethosuximide—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00033	0.00164	CcSEcCtD
Ethosuximide—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00033	0.00163	CcSEcCtD
Ethosuximide—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000329	0.00163	CcSEcCtD
Ethosuximide—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000329	0.00163	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000329	0.00163	CcSEcCtD
Ethosuximide—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000329	0.00163	CcSEcCtD
Ethosuximide—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000328	0.00162	CcSEcCtD
Ethosuximide—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000328	0.00162	CcSEcCtD
Ethosuximide—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000327	0.00162	CcSEcCtD
Ethosuximide—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000326	0.00162	CcSEcCtD
Ethosuximide—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000325	0.00161	CcSEcCtD
Ethosuximide—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000324	0.0016	CcSEcCtD
Ethosuximide—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000321	0.00159	CcSEcCtD
Ethosuximide—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.00032	0.00159	CcSEcCtD
Ethosuximide—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000318	0.00158	CcSEcCtD
Ethosuximide—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000317	0.00157	CcSEcCtD
Ethosuximide—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000316	0.00157	CcSEcCtD
Ethosuximide—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000316	0.00157	CcSEcCtD
Ethosuximide—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000314	0.00156	CcSEcCtD
Ethosuximide—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000312	0.00155	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000312	0.00154	CcSEcCtD
Ethosuximide—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000311	0.00154	CcSEcCtD
Ethosuximide—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000311	0.00154	CcSEcCtD
Ethosuximide—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000309	0.00153	CcSEcCtD
Ethosuximide—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000308	0.00153	CcSEcCtD
Ethosuximide—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000308	0.00153	CcSEcCtD
Ethosuximide—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000307	0.00152	CcSEcCtD
Ethosuximide—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000306	0.00152	CcSEcCtD
Ethosuximide—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000304	0.00151	CcSEcCtD
Ethosuximide—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000304	0.00151	CcSEcCtD
Ethosuximide—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000304	0.0015	CcSEcCtD
Ethosuximide—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000303	0.0015	CcSEcCtD
Ethosuximide—Rash—Didanosine—acquired immunodeficiency syndrome	0.000302	0.0015	CcSEcCtD
Ethosuximide—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000302	0.00149	CcSEcCtD
Ethosuximide—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000302	0.00149	CcSEcCtD
Ethosuximide—Headache—Didanosine—acquired immunodeficiency syndrome	0.0003	0.00149	CcSEcCtD
Ethosuximide—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000299	0.00148	CcSEcCtD
Ethosuximide—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000299	0.00148	CcSEcCtD
Ethosuximide—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000298	0.00148	CcSEcCtD
Ethosuximide—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000296	0.00147	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000295	0.00146	CcSEcCtD
Ethosuximide—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000295	0.00146	CcSEcCtD
Ethosuximide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000294	0.00146	CcSEcCtD
Ethosuximide—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000294	0.00146	CcSEcCtD
Ethosuximide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000292	0.00145	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000291	0.00144	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00029	0.00144	CcSEcCtD
Ethosuximide—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00029	0.00143	CcSEcCtD
Ethosuximide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000289	0.00143	CcSEcCtD
Ethosuximide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000287	0.00142	CcSEcCtD
Ethosuximide—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000286	0.00141	CcSEcCtD
Ethosuximide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000285	0.00141	CcSEcCtD
Ethosuximide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000284	0.00141	CcSEcCtD
Ethosuximide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000284	0.00141	CcSEcCtD
Ethosuximide—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000283	0.0014	CcSEcCtD
Ethosuximide—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000282	0.0014	CcSEcCtD
Ethosuximide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00028	0.00139	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.00028	0.00139	CcSEcCtD
Ethosuximide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000276	0.00137	CcSEcCtD
Ethosuximide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000276	0.00137	CcSEcCtD
Ethosuximide—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000275	0.00136	CcSEcCtD
Ethosuximide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000275	0.00136	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000275	0.00136	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000274	0.00136	CcSEcCtD
Ethosuximide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000274	0.00136	CcSEcCtD
Ethosuximide—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000274	0.00136	CcSEcCtD
Ethosuximide—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000273	0.00135	CcSEcCtD
Ethosuximide—CACNA1G—digestive system—acquired immunodeficiency syndrome	0.000272	0.126	CbGeAlD
Ethosuximide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000271	0.00134	CcSEcCtD
Ethosuximide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000271	0.00134	CcSEcCtD
Ethosuximide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000271	0.00134	CcSEcCtD
Ethosuximide—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00027	0.00134	CcSEcCtD
Ethosuximide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00027	0.00134	CcSEcCtD
Ethosuximide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000268	0.00133	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000267	0.00132	CcSEcCtD
Ethosuximide—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000267	0.00132	CcSEcCtD
Ethosuximide—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000266	0.00132	CcSEcCtD
Ethosuximide—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000265	0.00131	CcSEcCtD
Ethosuximide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000265	0.00131	CcSEcCtD
Ethosuximide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000264	0.00131	CcSEcCtD
Ethosuximide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000264	0.00131	CcSEcCtD
Ethosuximide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000263	0.0013	CcSEcCtD
Ethosuximide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000263	0.0013	CcSEcCtD
Ethosuximide—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000263	0.0013	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000262	0.0013	CcSEcCtD
Ethosuximide—Rash—Stavudine—acquired immunodeficiency syndrome	0.000262	0.0013	CcSEcCtD
Ethosuximide—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000262	0.0013	CcSEcCtD
Ethosuximide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000262	0.0013	CcSEcCtD
Ethosuximide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000261	0.00129	CcSEcCtD
Ethosuximide—Headache—Stavudine—acquired immunodeficiency syndrome	0.00026	0.00129	CcSEcCtD
Ethosuximide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00026	0.00129	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.00026	0.00129	CcSEcCtD
Ethosuximide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000259	0.00128	CcSEcCtD
Ethosuximide—Rash—Abacavir—acquired immunodeficiency syndrome	0.000258	0.00128	CcSEcCtD
Ethosuximide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000258	0.00128	CcSEcCtD
Ethosuximide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000258	0.00128	CcSEcCtD
Ethosuximide—Headache—Abacavir—acquired immunodeficiency syndrome	0.000256	0.00127	CcSEcCtD
Ethosuximide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000256	0.00127	CcSEcCtD
Ethosuximide—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000253	0.00125	CcSEcCtD
Ethosuximide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000252	0.00125	CcSEcCtD
Ethosuximide—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000251	0.00124	CcSEcCtD
Ethosuximide—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00025	0.00124	CcSEcCtD
Ethosuximide—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00025	0.00124	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000248	0.00123	CcSEcCtD
Ethosuximide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000248	0.00123	CcSEcCtD
Ethosuximide—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000247	0.00123	CcSEcCtD
Ethosuximide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000247	0.00122	CcSEcCtD
Ethosuximide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000247	0.00122	CcSEcCtD
Ethosuximide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000246	0.00122	CcSEcCtD
Ethosuximide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000244	0.00121	CcSEcCtD
Ethosuximide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000243	0.0012	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000242	0.0012	CcSEcCtD
Ethosuximide—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000242	0.0012	CcSEcCtD
Ethosuximide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000241	0.0012	CcSEcCtD
Ethosuximide—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000241	0.00119	CcSEcCtD
Ethosuximide—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.00024	0.00119	CcSEcCtD
Ethosuximide—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.00024	0.00119	CcSEcCtD
Ethosuximide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000239	0.00118	CcSEcCtD
Ethosuximide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000235	0.00116	CcSEcCtD
Ethosuximide—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000234	0.00116	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.00116	CcSEcCtD
Ethosuximide—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.00115	CcSEcCtD
Ethosuximide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00023	0.00114	CcSEcCtD
Ethosuximide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00023	0.00114	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.00114	CcSEcCtD
Ethosuximide—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000229	0.00114	CcSEcCtD
Ethosuximide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000228	0.00113	CcSEcCtD
Ethosuximide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000228	0.00113	CcSEcCtD
Ethosuximide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000228	0.00113	CcSEcCtD
Ethosuximide—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000226	0.00112	CcSEcCtD
Ethosuximide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000224	0.00111	CcSEcCtD
Ethosuximide—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000224	0.00111	CcSEcCtD
Ethosuximide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000223	0.00111	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000223	0.0011	CcSEcCtD
Ethosuximide—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.0011	CcSEcCtD
Ethosuximide—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000222	0.0011	CcSEcCtD
Ethosuximide—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000222	0.0011	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.00109	CcSEcCtD
Ethosuximide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000218	0.00108	CcSEcCtD
Ethosuximide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000217	0.00108	CcSEcCtD
Ethosuximide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000215	0.00106	CcSEcCtD
Ethosuximide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000215	0.00106	CcSEcCtD
Ethosuximide—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000214	0.00106	CcSEcCtD
Ethosuximide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000214	0.00106	CcSEcCtD
Ethosuximide—Rash—Indinavir—acquired immunodeficiency syndrome	0.000212	0.00105	CcSEcCtD
Ethosuximide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000212	0.00105	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.00104	CcSEcCtD
Ethosuximide—CACNA1G—nervous system—acquired immunodeficiency syndrome	0.00021	0.0977	CbGeAlD
Ethosuximide—Headache—Indinavir—acquired immunodeficiency syndrome	0.00021	0.00104	CcSEcCtD
Ethosuximide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00021	0.00104	CcSEcCtD
Ethosuximide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000208	0.00103	CcSEcCtD
Ethosuximide—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000207	0.00103	CcSEcCtD
Ethosuximide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000205	0.00101	CcSEcCtD
Ethosuximide—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000204	0.00101	CcSEcCtD
Ethosuximide—CACNA1G—central nervous system—acquired immunodeficiency syndrome	0.000203	0.094	CbGeAlD
Ethosuximide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000202	0.001	CcSEcCtD
Ethosuximide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.000998	CcSEcCtD
Ethosuximide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000201	0.000995	CcSEcCtD
Ethosuximide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.0002	0.000991	CcSEcCtD
Ethosuximide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.0002	0.00099	CcSEcCtD
Ethosuximide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.0002	0.000989	CcSEcCtD
Ethosuximide—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000199	0.000987	CcSEcCtD
Ethosuximide—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000199	0.000985	CcSEcCtD
Ethosuximide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000194	0.000961	CcSEcCtD
Ethosuximide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000193	0.000957	CcSEcCtD
Ethosuximide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.000952	CcSEcCtD
Ethosuximide—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000191	0.000949	CcSEcCtD
Ethosuximide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000191	0.000948	CcSEcCtD
Ethosuximide—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00019	0.000942	CcSEcCtD
Ethosuximide—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00019	0.000941	CcSEcCtD
Ethosuximide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000189	0.000934	CcSEcCtD
Ethosuximide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000186	0.00092	CcSEcCtD
Ethosuximide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000185	0.000917	CcSEcCtD
Ethosuximide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.000916	CcSEcCtD
Ethosuximide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00018	0.000894	CcSEcCtD
Ethosuximide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.000885	CcSEcCtD
Ethosuximide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.000885	CcSEcCtD
Ethosuximide—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.000877	CcSEcCtD
Ethosuximide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.000876	CcSEcCtD
Ethosuximide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.000874	CcSEcCtD
Ethosuximide—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.000872	CcSEcCtD
Ethosuximide—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000174	0.0805	CbGeAlD
Ethosuximide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.000851	CcSEcCtD
Ethosuximide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.000845	CcSEcCtD
Ethosuximide—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000844	CcSEcCtD
Ethosuximide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000844	CcSEcCtD
Ethosuximide—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.000839	CcSEcCtD
Ethosuximide—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.000826	CcSEcCtD
Ethosuximide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000812	CcSEcCtD
Ethosuximide—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000805	CcSEcCtD
Ethosuximide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000805	CcSEcCtD
Ethosuximide—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.000162	0.0751	CbGeAlD
Ethosuximide—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.0008	CcSEcCtD
Ethosuximide—CACNA1G—brain—acquired immunodeficiency syndrome	0.000161	0.0746	CbGeAlD
Ethosuximide—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000161	0.000795	CcSEcCtD
Ethosuximide—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.000759	CcSEcCtD
Ethosuximide—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00013	0.0604	CbGeAlD
Ethosuximide—CYP3A5—digestive system—acquired immunodeficiency syndrome	6.67e-05	0.031	CbGeAlD
Ethosuximide—CYP3A5—blood—acquired immunodeficiency syndrome	6.36e-05	0.0295	CbGeAlD
Ethosuximide—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	6.3e-05	0.0292	CbGeAlD
Ethosuximide—CYP2E1—digestive system—acquired immunodeficiency syndrome	6.22e-05	0.0289	CbGeAlD
Ethosuximide—CYP2E1—blood—acquired immunodeficiency syndrome	5.93e-05	0.0275	CbGeAlD
Ethosuximide—CYP3A5—vagina—acquired immunodeficiency syndrome	5.89e-05	0.0273	CbGeAlD
Ethosuximide—CYP2E1—spinal cord—acquired immunodeficiency syndrome	5.71e-05	0.0265	CbGeAlD
Ethosuximide—CYP3A5—lung—acquired immunodeficiency syndrome	5.57e-05	0.0259	CbGeAlD
Ethosuximide—CYP2E1—lung—acquired immunodeficiency syndrome	5.2e-05	0.0241	CbGeAlD
Ethosuximide—CYP3A4—digestive system—acquired immunodeficiency syndrome	5.01e-05	0.0232	CbGeAlD
Ethosuximide—CYP2E1—nervous system—acquired immunodeficiency syndrome	4.81e-05	0.0223	CbGeAlD
Ethosuximide—CYP3A4—blood—acquired immunodeficiency syndrome	4.77e-05	0.0221	CbGeAlD
Ethosuximide—CYP2E1—central nervous system—acquired immunodeficiency syndrome	4.63e-05	0.0215	CbGeAlD
Ethosuximide—CYP3A4—nervous system—acquired immunodeficiency syndrome	3.87e-05	0.018	CbGeAlD
Ethosuximide—CYP3A4—central nervous system—acquired immunodeficiency syndrome	3.73e-05	0.0173	CbGeAlD
Ethosuximide—CYP2E1—brain—acquired immunodeficiency syndrome	3.68e-05	0.0171	CbGeAlD
